Tech group seeks more access to corporate employees in bid for foothold in $4tn healthcare market
Related Posts
Servier Clinches Day One Biopharma for $2.5 Billion, Solidifying Rare Oncology Foothold
French pharmaceutical giant Servier has moved decisively to bolster its targeted therapy pipeline, announcing a definitive agreement to acquire Day One Biopharmaceuticals (NASDAQ: DAWN) in an...
Sanofi Divests Brazilian Generics Unit Medley to EMS in Strategic Exit
Paris-headquartered pharmaceutical giant Sanofi has agreed to divest its Brazilian generics unit, Medley, to local drugmaker EMS, in a move signaling further streamlining of its global portfolio and...
Novo’s $2.1B Vivtex Deal Boosts Obesity Drug Pipeline
Novo Nordisk entered a partnership worth up to $2.1 billion with Vivtex Corp. to develop next-generation oral medicines for obesity and diabetes, leveraging Vivtex's drug delivery technology to...
GSK Secures Potential ‘Multi-Blockbuster’ Drug in $950 Million 35Pharma Acquisition
null GlaxoSmithKline announced today that it has acquired 35Pharma Inc., a Montreal-based clinical-stage biopharmaceutical company, for $950 million in cash. The deal grants GSK access to HS235, an...